RespireRx Pharmaceuticals Inc (RSPI)

[Xtremetz1]

I'm guessing that we will need some DD experts that know how to research NIH testing results as well as funding requests. They will also need to know how long it typically takes for phase 3 animal testing to be set up and then completed. Once we have that info. We will be able to better predict the run timing of this company as well as the funding or partnership potential for the company. The company needs to continue to drive awareness about the status of their drugs that are in the pipeline as well as potential timing of test results or test launch dates. I'm not sure but I thought the share structure was low on this company. Something like 600 million shares and not the typical 2 to 4 billion shares. That would give them room to dilute 400million shares for support with funding if they don't get NIH approved funding. Not sure with the focus on pain replacement drugs from the NIH. Why they wouldn't want to grant funding to any potential drug that shows promise in bringing an end to this epidemic. IMO. This companies potential is off the charts to push through the process on their own if the NIH approves funding but if for some reason the answer is no. Then BP will want in on this company. This could be a epic run on short notice in 2024 by this company. Load up while you can because these prices will not last. Patients is key but it wont be long if the phase 3 animal tests have similar results as the last two phases.